Dhanya Dharman | Pharmacology | Best Research Article Award

Published on by Best Paper Awards

Best Research Article Award

Dhanya Dharman
Dr Moopens College of Pharmacy, India
Paper Title: Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study

Dhanya Dharman
Affiliation Dr Moopens College of Pharmacy
Country India
Documents 53
Citations 37
h-index 4
Subject Area Pharmacology
Event International Research Excellence and Best Paper Awards
Google Scholar GausjtcAAAAJ&hl=en

Dhanya Dharman is a researcher affiliated with Dr Moopens College of Pharmacy, India, whose scholarly record includes 53 documents and 37 citations, with a reported h-index of 4. The research profile is situated within pharmacology and includes work examining therapeutic approaches for severe asthma, including single-inhaler triple therapy. [1]

Abstract

Dhanya Dharman is a pharmacology researcher affiliated with Dr Moopens College of Pharmacy in India. Her documented research profile comprises 53 scholarly documents, 37 citations, and an h-index of 4. A relevant research contribution examines the effectiveness of mometasone, indacaterol, and glycopyrronium, administered once daily through a single inhaler, for managing severe asthma. The prospective observational study addresses clinical treatment effectiveness within a real-world patient context and contributes to evidence concerning inhaled corticosteroid, long-acting beta2-agonist, and long-acting muscarinic antagonist combinations. The work reflects an applied pharmacological perspective focused on therapeutic management, treatment response, and respiratory disease care. [1]

Keywords

Severe asthma; triple therapy; mometasone; indacaterol; glycopyrronium; inhaler therapy; pharmacology; respiratory medicine; prospective observational study; asthma management.

Introduction

Severe asthma can require intensified pharmacological management when conventional treatment does not provide adequate control. Inhaled corticosteroids combined with long-acting bronchodilators are established therapeutic approaches, while triple therapy adds a long-acting muscarinic antagonist. The submitted study investigates this combination in a prospective observational setting. [1]

Research Profile

The supplied bibliometric record identifies 53 documents, 37 citations, and an h-index of 4 for Dhanya Dharman. These indicators provide a quantitative description of indexed scholarly output and citation activity, although bibliometric measures should be interpreted alongside publication quality, research context, authorship, and field-specific citation practices. [1]

Research Contributions

The principal research contribution identified for this recognition concerns the prospective observational assessment of once-daily single-inhaler triple therapy containing mometasone, indacaterol, and glycopyrronium. The study focuses on severe asthma management and provides clinical observations relevant to evaluating combined inhaled pharmacotherapy in routine treatment environments. [2]

Publications

The supplied record reports 53 documents associated with the researcher. The specifically identified paper is titled Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study. Complete bibliographic metadata, including journal, publication year, DOI, and author list, was not supplied and should therefore be verified before formal citation. [1]

Research Impact

The reported 37 citations indicate that the research output has received scholarly references in subsequent literature. Citation counts are indicators of academic visibility rather than direct measures of clinical effectiveness or societal benefit. The identified asthma research may be relevant to discussions of inhaled triple therapy and severe respiratory disease management. [1]

Award Suitability

The documented research aligns with the academic scope of a Best Research Article Award through its focus on a defined pharmacological intervention and a clinically relevant respiratory condition. Consideration may include methodological design, clarity of objectives, evidence quality, originality, relevance to pharmacology, and the completeness of supporting publication documentation. [2]

Conclusion

Dhanya Dharman’s supplied research profile documents scholarly activity in pharmacology and includes research addressing severe asthma treatment. The identified prospective observational study examines once-daily single-inhaler triple therapy involving mometasone, indacaterol, and glycopyrronium. Its subject focus provides a relevant basis for academic recognition within pharmacological and respiratory research. [1]

References

    1. Ramesan, R. (n.d.). Google Scholar profile. Google Scholar.
      Google Scholar Profile

    2. The era of pharmacovigilance and the need of pharmacovigilance in psychiatry: A review.
      https://www.researchgate.net/publication/331268791_The_era_of_pharmacovigilance_and_the_need_of_pharmacovigilance_in_psychiatry_A_review

    3. A cross sectional study of polycystic ovarian syndrome among pharmacy students.
      https://www.researchgate.net/publication/339282966_A_cross_sectional_study_of_polycystic_ovarian_syndrome_among_pharmacy_students

Luisa Pozzo | Pharmacology | Excellence in Research Award

Published on by Best Paper Awards

Assoc. Prof. Dr. Luisa Pozzo | Pharmacology | Excellence in Research Award 

Senior Researcher | IBBA-CNR | Italy

Assoc. Prof. Dr. Luisa Pozzo is a distinguished senior researcher with over fifteen years of continuous, high-impact contributions to food science, toxicology, nutraceuticals, and preclinical disease models, currently serving at the National Research Council of Italy through the Institute of Agricultural Biology and Biotechnology. Her internationally recognized expertise lies in the biofunctional characterization of food products, oxidative stress, inflammation, nonalcoholic fatty liver disease, neurodegeneration, and novel food safety using validated mouse and rat models, with strong relevance to human health and predictive toxicology. She has authored more than 45 peer-reviewed publications in prestigious Q1 journals including Food Chemistry, Nutrients, Antioxidants, Molecules, Scientific Reports, and Food and Chemical Toxicology, reflecting exceptional productivity, quality, and global scientific influence. As Principal Investigator and scientific referent for multiple competitive national and international projects funded by the Italian Ministry of University and Research, Horizon Europe, regional authorities, and bilateral collaborations with Poland, Egypt, and Slovakia, she has demonstrated outstanding leadership in translational and multidisciplinary research. Her academic service includes long-standing editorial roles as Section Editor of the Polish Journal of Food and Nutrition Sciences, Topic Editor of Frontiers in Toxicology, and Guest Editor of Foods. She is also a committed educator and mentor, having taught Applied Nutraceuticals for nearly a decade at the University of Pisa while supervising PhD, postdoctoral, and postgraduate researchers internationally. Her consistent scientific excellence, grant leadership, editorial influence, mentoring impact, and translational outcomes firmly establish her as a highly deserving candidate for an Excellence in Research Award.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Trouki, C., Campanella, B., Onor, M., Vornoli, A., Pozzo, L., Longo, V., & Bramanti, E. (2024). Probing the alterations in mice cecal content due to high-fat diet. Food Chemistry, 430, 139856.

  2. Souid, A., Giambastiani, L., Castagna, A., Santin, M., Vivarelli, F., Canistro, D., Morosini, C., Paolini, M., Franchi, P., Lucarini, M., Raffaelli, A., Giorgetti, L., Ranieri, A., Longo, V., Pozzo, L., & Vornoli, A. (2024). Assessment of the antioxidant and hypolipidemic properties of Salicornia europaea for the prevention of TAFLD in rats. Antioxidants, 13(5), 596.

  3. Wijaya, G. Y. A., Vornoli, A., Giambastiani, L., Digiacomo, M., Macchia, M., Szymczak, B., Wójcik, M., Pozzo, L., & Longo, V. (2025). Solid-state fermented cereals: Increased phenolics and their role in attenuating liver diseases. Nutrients, 17(5), 900.

  4. Tancreda, G., Campisi, L., Sarti, M., Pozzo, L., & Vornoli, A. (2025). Perfluoroalkyl substances (PFAS) and lipid metabolism in experimental animal models: A scoping review on the mechanisms behind the induced hepatotoxicity. Current Issues in Molecular Biology, 47(11), 0000.

  5. Amin, A. A., Mahmoud, K. F., Salama, M. F., Longo, V., Pozzo, L., Seliem, E. I., & Ibrahim, M. A. (2023). Characterization and stability evaluation of Egyptian propolis extract nano-capsules and their application. Scientific Reports, 13, 42025.

Assoc. Prof. Dr. Luisa Pozzo’s research advances global understanding of how bioactive foods and nutraceuticals can prevent chronic diseases through precise preclinical and toxicological validation. Her work bridges fundamental science with food safety, sustainable nutrition, and human health, driving innovation across academia, industry, and public health sectors.